Skip to content
The reference academic journal by and for the Asia-Pacific interventional cardiology community
AsiaIntervention

AsiaIntervention

  • Current issue
  • Archives
  • How to submit
    • Authors guidelines
    • Submit your paper
    • Reviewers guidelines
  • Services
    • Advertising
    • Article reprints
    • Publication calendar
    • Rights & Permissions
  • About the journal
    • Overview
    • Editorial Board
    • Masthead
  • Contact us
Volume 11 – Number 3 – October 2025

Rare and rapid: immediate development of coronary artery aneurysms following drug-eluting stenting

AsiaIntervention 2025;11:219-220 | 10.4244/AIJ-D-24-00073

Prerna Garg1, MD, DM; Mohsin Raj1, MD, DM; Manjit Mahendran2, MD, DM; Satyavir Yadav1, MD, DM; Neeraj Parakh1, MD, DM; Balram Bhargava1, MD, DM

1. All India Institute of Medical Sciences, New Delhi, India; 2. JIPMER, Pondicherry, India

The patient, a 64-year-old male with a history of smoking, presented with worsening angina over the previous four months. He had a history of anterior wall ST-segment elevation myocardial infarction five months prior, for which he underwent primary percutaneous coronary intervention (PCI) to the left anterior descending artery (LAD). Two drug-eluting stents (DES) were implanted: an everolimus-eluting XIENCE Prime (3.0×28 mm; Abbott) in the proximal to mid-LAD and a biodegradable-polymer sirolimus-eluting Supralimus Grace (2.75×48 mm; Sahajanand Medical Technologies) in the mid- to distal LAD (Figure 1A, Figure 1B, Moving image 1). One week later, the patient suffered from an episode of unstable angina. Coronary angiography revealed multiple aneurysms in the LAD starting from the proximal edge of the distal stent (Figure 1C, Figure 1D, Moving image 2). The patient opted for medical management; however, his angina did not improve. The patient had mild left ventricular dysfunction with LAD territory hypokinesia. An electrocardiogram showed normal sinus rhythm with poor R wave progression without Q waves. His blood workup and cardiac 18F-fluorodeoxyglucose positron emission tomography were not suggestive of infection (total leucocyte count 8,400 cells/mm3, erythrocyte sedimentation rate 10 mm/hr, C-reactive protein 3 mg/dL, procalcitonin <0.05 ng/mL, blood cultures negative). Repeat coronary angiography showed multiple saccular aneurysms in the mid- to distal LAD (largest diameter 7 mm) with contrast stasis and distal slow flow. Mild diffuse in-stent restenosis was also present in the proximal stent (Figure 1E, Moving image 3). After shared decision-making with the Heart Team, a percutaneous approach was planned for the patient. Pre-PCI optical coherence tomography revealed the stent edges hanging freely at the sites of saccular aneurysms, with mild neointimal hyperplasia in the parts without aneurysms (Figure 1G–Figure 1H–Figure 1I–Figure 1J–Figure 1K, Moving image 4). The aneurysms were successfully managed with two overlapping covered stents, GRAFTMASTER RX (Coronary Stent Graft System [Abbott]), sized 2.8×26 mm and 2.8×19 mm. Post-PCI, there was complete disappearance of the aneurysms and Thrombolysis in Myocardial Infarction 3 flow in the LAD was achieved (Figure 1F, Moving image 5). The patient had significant symptom improvement at 1-year follow-up. Coronary artery aneurysms occurring after percutaneous interventions with DES are rare, with a reported incidence of 0.2-2.3%1. Acute aneurysms, occurring within four weeks of procedure are usually due to injury to the vessel wall from high-pressure balloons, oversized stents, or deep resections using laser atherectomy2. Natural endothelisation and healing are inhibited by the action of antiproliferative agents in DES, while shear stress from blood flow causes further progression. Subacute aneurysms may represent a hypersensitivity response to the DES, while infective aneurysms can present at any time345. In our patient, the acute onset of large aneurysms, in the absence of infection, suggests that mechanical injury during the index procedure was the most likely cause of aneurysm formation. Treatment options include medical therapy (antiplatelets or anticoagulants), percutaneous therapy (either covered stents or coil embolisation), and surgical treatment. Infected aneurysms should be resected. Other patients may be offered the options of surgery or percutaneous intervention based on the amenability of the lesion to intervention. Patients who are asymptomatic with small aneurysms that do not progress may be kept on close follow-up with coronary computed tomography angiography. This report highlights acute coronary artery aneurysm development as an uncommon but urgent cause of post-PCI angina, which may occur as early as one week, emphasising that intracoronary imaging is vital in determining the mechanism of injury and guiding management.

Figure 1. Coronary artery aneurysms after DES PCI. A) Index presentation of anterior wall STEMI, with the infarct-related artery identified as the left anterior descending artery (LAD). The initial angiogram revealed a patent vessel, likely due to spontaneous recanalisation, along with significant mid-LAD disease. The distal vessel is noted to be of thin calibre. B) Percutaneous coronary intervention (PCI) was performed using drug-eluting stents (DES) in the LAD, resulting in TIMI 3 flow. A slight step-down is observed just distal to the distal stent, likely indicative of stent edge dissection or stent oversizing. C) One week post-PCI, the patient presented with unstable angina. Repeat angiography demonstrated the presence of multiple saccular aneurysms in the LAD, originating just distal to the proximal stent. (D,E) Progression in both the size and number of the aneurysms over time. F) Following the deployment of covered stents, TIMI 3 flow was achieved in the LAD with no residual aneurysms observed. (G,H) Optical coherence tomography (OCT) prior to deployment of the covered stent revealed multiple aneurysms beginning at the proximal edge of the distal stent, with no evidence of thrombus or mass present within the aneurysms. I) Proximal fibrous in-stent restenosis on OCT. (J,K) Further OCT imaging confirmed multiple aneurysms starting from the proximal edge of the distal stent, again with no evidence of thrombus or mass noted within the aneurysms. TIMI: Thrombolysis in Myocardial Infarction

Conflict of interest statement

The authors have no conflicts of interest to declare in relation to this manuscript.

Share

References

  • Aoki J, Kirtane A, Leon MB, Dangas G. Coronary artery aneurysms after drug-eluting stent implantation. JACC Cardiovasc Interv 2008;1:14-21
  • Slota PA, Fischman DL, Savage MP, Rake R, Goldberg S. Frequency and outcome of development of coronary artery aneurysm after intracoronary stent placement and angioplasty. STRESS Trial Investigators. Am J Cardiol 1997;79:1104-6
  • van der Giessen WJ, Lincoff AM, Schwartz RS, van Beusekom HM, Serruys PW, Holmes DR Jr, Ellis SG, Topol EJ. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 1996;94:1690-7
  • Nair RG, Vellani H, Muneer K, Pillai RS, Chaithanya PT, Alur S, Ameen M, Anand V. Infective endarteritis of coronaries following percutaneous coronary intervention (stentocarditis) leading to pseudoaneurysm – a retrospective study of eleven cases. AsiaIntervention 2024;10:126-34
  • Dhall A, Punamiya K. Stent infections: elephant in the room. AsiaIntervention 2024;10:100-1

Volume 11 - Number 3

View full issue

Download this article
Authors
  • Balram Bhargava
  • Manjit Mahendran
  • Mohsin Raj
  • Neeraj Parakh
  • Prerna Garg
  • Satyavir Yadav
AsiaIntervention
  • Readers
    • Archives
    • Subscribe to the newsletter
    • Contact us
  • About the journal
    • Overview
    • Editorial Board
    • Masthead
  • Services
    • Advertising in AsiaIntervention
    • Article reprints
    • Publication calendar
    • Rights & Permissions
  • Authors
    • Authors guidelines
    • Submit your paper
  • Legal
    • Disclaimer
    • Cookies Policy
    • Privacy Policy
    • Legal Notice
  • Follow us
    • Facebook
    • X
    • LinkedIn
Online ISSN 2491-0929 - Print ISSN 2426-3958
© 2015-2025 Europa Group - All rights reserved